|
基于网络药理学及分子对接技术探究半夏泻心汤治疗失眠的作用机制
|
Abstract:
基于网络药理学及分子对接技术探究半夏泻心汤治疗失眠的作用机制。方法:通过TCMSP数据库,获取半夏泻心汤中各药物的活性成分及其作用靶点,利用UniProt数据库规范靶点名称。在OMIM、TTD、DrugBank、GeneCards数据库中检索失眠的相关靶点。运用在线Venny作图平台,得到半夏泻心汤治疗失眠的潜在作用靶点。将得到的作用靶点导入String数据库构建PPI网络,将所得蛋白互作信息导入Cytoscape3.9.1进行图像优化及提取核心基因,并构建疾病–药物–成分–靶点网络图。利用Metascape平台分别对交集靶点进行GO富集分析及KEGG通路富集分析。将核心成分及靶点运用Autodock软件进行分子对接验证。结果:得到半夏泻心汤有效成分184个,靶点249个,失眠相关靶点1701个,交集靶点95个,24核心靶点。富集分析得到GO条目1567条,KEGG通路185条,主要涉及神经活性配体–受体相互作用通路、TNF信号通路等。分子对接结果显示,上述活性成分与相关靶点具有较好的结合活性。结论:本研究初步表明了半夏泻心汤可以通过多成分、多靶点、多通路治疗失眠,为临床用药和进一步研究提供了一定参考。
To explore the mechanism of Banxia Xiexin Decoction in treating insomnia based on network pharmacology and molecular docking technology. Methods: The active ingredients and their targets in Banxia Xiexin Decoction were obtained by TCMSP database, and the target names were standardized by UniProt database. Relevant targets for insomnia were searched in OMIM, TTD, DrugBank, GeneCards databases. Using online Venny mapping platform, the potential targets of Banxia Xiexin Decoction for insomnia were obtained. The obtained targets were imported into String database to construct PPI network, and the protein interaction information was imported into Cytoscape 3.9.1 for image optimization and core gene extraction, and the disease-drug-component-target network map was constructed. GO enrichment analysis and KEGG pathway enrichment analysis were performed for intersection targets using Metascape platform. The core components and targets were verified by using Autodock software. Results: 184 effective components of Banxia Xiexin Decoction, 249 targets, 1701 insomnia related targets, 95 intersection targets and 24 core targets. Enrichment analysis showed that there were 1567 GO entries and 185 KEGG pathways, which mainly involved the neural active ligand-receptor interaction pathway and TNF signaling pathway. The results of molecular docking showed that the active constituents had good binding activity with related targets. Conclusion: This study preliminically indicates that Banxia Xiexin Decoction can treat insomnia through multi-component, multi-target and multi-pathway, which provides certain reference for clinical medication and further research.
[1] | 刘帅, 张斌. 《中国失眠障碍诊断和治疗指南》解读[J]. 中国现代神经疾病杂志, 2017(9): 633-638. |
[2] | Sateia, M.J. (2014) International Classification of Sleep Disorders-Third Edition: Highlights and Modifications. Chest, 146, 1387-1394. https://doi.org/10.1378/chest.14-0970 |
[3] | 葛旭峰, 马长林, 张莉, 等. 失眠症患者多导睡眠图的临床研究[J]. 临床精神医学杂志, 2023, 33(1): 59-61. |
[4] | Roth, T. and Drake, C. (2004) Evolution of Insomnia: Current Status and Future Direction. Sleep Medicine, 5, S23-S30.
https://doi.org/10.1016/S1389-9457(04)90004-4 |
[5] | 苏亮, 陆峥. 2017年中国失眠症诊断和治疗指南解读[J]. 世界临床药物, 2018, 39(4): 217-222. |
[6] | 于臻, 边新娜, 韩文文, 等. 失眠的中医证治研究进展[J]. 西部中医药, 2020, 33(1): 151-154. |
[7] | 王亮, 王鹏, 侯晓圆, 等. 和胃安神方治疗失眠的网络药理学和分子对接机制研究[J]. 世界中医药, 2022, 17(5): 671-677. |
[8] | 于晓艳. 论胃不和则卧不安[J]. 福建中医药大学学报, 2014, 24(3): 57-58. |
[9] | 李静, 郑柳怡, 黄惠琼, 等. 补中益气安神汤对脾虚失眠大鼠CREB/BDNF/TrkB信号通路的影响[J]. 今日药学, 2021, 31(11): 834-838+843. |
[10] | 王德民. 半夏泻心汤的临床应用体会[J]. 中国社区医师, 2018, 34(18): 103+105. |
[11] | 《网络药理学评价方法指南》发布[J]. 中国新药与临床杂志, 2021, 40(5): 361. |
[12] | 苟永鹏, 张筱微, 孙少卫, 等. 失眠症中西医治疗进展综述[J]. 中国疗养医学, 2022, 31(5): 483-491. |
[13] | 许晓伍, 黄妙纯, 刘凤岚, 等. 失眠的病因学研究进展[J]. 世界睡眠医学杂志, 2017, 4(5): 307-312. |
[14] | 刘恋, 李梦瑶, 吴清明. 《内经》关于睡眠与失眠理论探析[J]. 中医药通报, 2013, 12(5): 19-22. |
[15] | 李智欣, 杨中平, 石宝霞, 等. 夜交藤中改善睡眠成分的研究[J]. 食品科学, 2007(4): 327-331. |
[16] | 张胜, 张尧, 李彪, 等. 山奈酚对CUMS抑郁模型大鼠海马神经元过度自噬和氧化应激损伤的保护作用[J]. 中国免疫学杂志, 2019, 35(2): 146-150+155. |
[17] | 刘梦, 张文静, 吕穆杰, 等. 川芎红花药对“异病同治”缺血性脑卒中和失眠中的机制分析[J]. 中医药临床杂志, 2022, 34(4): 687-696. |
[18] | Haque Md, N. and Moon, I.S. (2018) Stigmasterol Upregulates Immediate Early Genes and Promotes Neuronal Cytoarchitecture in Primary Hippocampal Neurons as Revealed by Transcriptome Analysis. Phytomedicine, 46, 164-175.
https://doi.org/10.1016/j.phymed.2018.04.012 |
[19] | 靳鸽, 冯志海, 赵一冰, 等. 回顾性“真实世界”研究原发性失眠中医证治规律及高频中药的作用机制[J]. 中国医院药学杂志, 2022, 42(5): 549-554. |
[20] | Rockstrom, M.D., Chen, L., Taishi, P., et al. (2018) Tumor Necrosis Factor Alpha in Sleep Regulation. Sleep Medicine Reviews, 40, 69-78. https://doi.org/10.1016/j.smrv.2017.10.005 |
[21] | Pandhare, A., Pappu, A.S., Wilms, H., et al. (2017) The Antidepressant Bupropion Is a Negative Allosteric Modulator of Serotonin Type 3A Receptors. Neuropharmacology, 113, 89-99. https://doi.org/10.1016/j.neuropharm.2016.09.021 |
[22] | Ibarra-Coronado, E.G., Pantaleón-Martínez, A., Velazquéz-Moctezuma, J., et al. (2015) The Bidirectional Relationship between Sleep and Immunity against Infections. Journal of Immunology Research, 2015, Article ID: 678164.
https://doi.org/10.1155/2015/678164 |